心内膜下受累:心肌炎中未被充分认识的心脏MRI表型
这项回顾性研究评估了2015至2020年间39例经心内膜心肌活检或移植病理证实的心肌炎患者,按心脏MRI表型分为心内膜下受累组18例和无心内膜下受累组21例。心内膜下受累组左心室射血分数更低(27%±11 vs 41%±19,P=.004)、LGE范围更大(中位数13% vs 5%,P<.001)、心脏死亡或移植率更高(44% vs 4.8%,P=.006),且巨细胞心肌炎比例更高(33% vs 4.8%,P=.02)、MACE更多(83% vs 33%,P=.002)。作者结论认为心内膜下受累提示更严重的临床特征和更差的预后。
要点
- 心脏MRI发现心内膜下LGE的心肌炎患者左心室射血分数更低(27%±11 vs 41%±19,P=.004)、LGE范围更大(中位数13% vs 5%,P<.001)。
- 心内膜下受累组心脏死亡或移植率44%(8/18)vs 4.8%(1/21),P=.006;MACE发生率83%(15/18)vs 33%(7/21),P=.002。
- 心内膜下受累组巨细胞心肌炎比例33%(6/18)vs 4.8%(1/21),P=.02;在LGE范围和射血分数可比的亚组中MACE差异仍存在(88% vs 50%,P=.02)。
核心结论
- 心脏MRI检测到的心内膜下受累提示心肌炎患者临床特征更严重,包括更频繁的严重淋巴细胞性心肌炎或巨细胞心肌炎,以及更差的预后。
研究设计与样本
- 回顾性研究,纳入2015至2020年间39例经心内膜心肌活检或移植病理证实的心肌炎患者,按心脏MRI表型分为心内膜下受累组18例(平均年龄40岁±17,10例女性)和无心内膜下受累组21例(平均年龄35岁±11,6例女性);中位随访784天(IQR 90-1123天);统计采用Student t检验、Mann-Whitney U检验和单变量Cox回归。
关键影像表现/征象
- 心内膜下受累组18例中12例(67%)为淋巴细胞性心肌炎,6例(33%)为巨细胞心肌炎。
- 心内膜下受累组LGE范围中位数13%(IQR 10%-22%),无心内膜下受累组中位数5%(IQR 2%-17%),P<.001。
诊断标准与关键数值
- 心内膜下受累组左心室射血分数平均27%±11 vs 无心内膜下受累组41%±19,P=.004。
- 心内膜下受累组心脏死亡或移植8/18(44%)vs 无心内膜下受累组1/21(4.8%),P=.006。
- 心内膜下受累组巨细胞心肌炎6/18(33%)vs 无心内膜下受累组1/21(4.8%),P=.02。
- 心内膜下受累组MACE 15/18(83%)vs 无心内膜下受累组7/21(33%),P=.002。
- LGE范围可比亚组(中位数15% vs 16%,P=.40)且左心室射血分数可比(中位数27% vs 31%,P=.26)时,MACE差异仍存在:15/17(88%)vs 5/10(50%),P=.02。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Subendocardial late gadolinium enhancement (LGE) detected with cardiac MRI in myocarditis represents a diagnostic dilemma, since it may resemble myocardial ischemia. Purpose To explore and compare the histopathologic characteristics and clinical features and outcomes in patients with myocarditis with and without subendocardial involvement at cardiac MRI. Materials and Methods This retrospective study evaluated 39 patients with myocarditis pathologically proven by means of either endomyocardial biopsy or explant pathologic findings between 2015 and 2020. Patients were divided into two groups according to cardiac MRI phenotype: 18 with subendocardial involvement (mean age ± standard deviation, 40 years ± 17; 10 women) and 21 with no subendocardial involvement (mean age, 35 years ± 11; six women). The median follow-up period was 784 days (interquartile range [IQR], 90-1123 days). The Student t test, Mann-Whitney U test, and univariable Cox regression were used for statistical analyses. Results In the 18 patients with subendocardial involvement, 12 (67%) had lymphocytic myocarditis and six (33%) had giant cell myocarditis. Patients with subendocardial involvement compared with those without subendocardial involvement had lower left ventricular ejection fraction (mean ± standard deviation, 27% ± 11 vs 41% ± 19; P = .004), larger LGE extent (median, 13% [IQR, 10%-22%] vs 5% [IQR, 2%-17%]; P < .001), higher rates of cardiac death or transplant (eight of 18 patients [44%] vs one of 21 patients [4.8%]; P = .006), higher probability of giant cell myocarditis (six of 18 [33%] vs one of 21 [4.8%]; P = .02), and more major adverse cardiovascular events (MACE) (15 of 18 [83%] vs seven of 21 [33%]; P = .002). In a subgroup of patients with comparable LGE extent (median, 15% vs 16%; P = .40) and left ventricular ejection fraction (median, 27% vs 31%; P = .26), the prognostic difference in terms of MACE remained (15 of 17 patients [88%] vs five of 10 [50%]; P = .02). Conclusion Subendocardial involvement detected with cardiac MRI in myocarditis indicated more severe clinical features, including a higher frequency of severe lymphocytic myocarditis or giant cell myocarditis and worse prognosis. © RSNA, 2021 See also the editorial by de Roos in this issue.
引用
- Li JH, Xu XQ, Zhu YJ, et al. Subendocardial Involvement as an Underrecognized Cardiac MRI Phenotype in Myocarditis. Radiology. 2021. PMID: 34636636. doi:10.1148/radiol.2021211276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。